BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 21, 2009
View Archived Issues
Cytos Shares Plunge as Vaccine Trial Misses Main Endpoint
Cytos Biotechnology AG lost almost one-third of its value Friday on news that its therapeutic vaccine for nicotine addiction failed to show efficacy in a Phase II study. (BioWorld International)
Read More
Viriom Taking Over Development of HIV Treatments in Roche Deal
Read More
New Assay Promises Genetic Analysis of Bacterial Pathogens
Read More
Biovitrum, Biogen Idec Eye 2011 Filing for Recombinant Factor IX
Read More
Oxford BioMedica Seeks OK to Boost ProSavin Dose Level
Read More
EU Spending Watchdog Criticizes Framework Project Structures
Read More
On Heels of Expanded Merck Deal, Galapagos Raises $27M
Read More
Other News To Note
Read More